Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study

European Journal of Heart Failure

Volumn 4, Issue 3, 2002, Pages 337-343

  Alla, François ^a   Briançon, Serge ^a   Guillemin, Francis ^a   Juillière, Yves ^a   Mertès, Paul Michel ^a   Villemot, Jean Pierre ^a   Zannad, Faiez ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Heart failure; Prognosis; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EDEMA; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOTENSION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MENTAL HEALTH; OUTCOMES RESEARCH; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF EVALUATION; SOCIAL ASPECT; SURVIVAL RATE; TREATMENT PLANNING; VALIDATION PROCESS;

ANALYSIS OF VARIANCE; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL RATE;

EID: 0036623938     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00006-5     Document Type: Article

References (36)

1. Leidy NK, Rentz AM, Zyczynski TM. Evaluating health-related quality-of-life outcomes in patients with congestive heart failure. Pharmacoeconomics 1999;15:19-46.
2. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
3. Berry C, McMurray J. A review of quality-of-life evaluations in patients with congestive heart failure. Pharmacoeconomics 1999;16:247-71.
4. Hunt SM, McKenna SP, McEwen J, Backett EM, William J, Papp E. A quantitative approach to perceived health status: a validation study. J Epidemiol Commun Health 1980;34:281-6.
5. Bergner M, Bobbit RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
6. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36):II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31(3):247-63.
7. Parkerson GR, Broadhead WE, Tse C-KJ. The Duke Health Profile. A 17 item measure of health and dysfunction. Med Care 1990;28(11):1056-69.
8. Guyatt GH, Nogradi S, Halcrow S. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med 1989;4:101-7.
9. Feinstein AR, Fisher MB, Pigeon JG. Changes in dyspneafatigue ratings as indicators of quality of life in the treatment of congestive heart failure. Am J Cardiol 1989;64:50-5.
10. Wiklund I, Lindvall K, Swedberg K, Zupkis RV. Self-assessment of quality of life in severe heart failure. Scand J Psychol 1987;28:220-5.
11. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987;3:198-209.
12. Shively M, Fox C, Brass-Mynderse NJ. Health-related quality of life as an outcome for patients with heart failure. J Cardiovasc Nurs 1996;10:89-96.
13. Konstam V, Salem D, Pouleur H, et al. Baseline quality of life as a predictor of mortality and hospitalisation in 5,025 patients with congestive heart failure. Am J Cardiol 1996;78:890-5.
14. Murberg TA, Bru E, Svebak S, Tveteras R, Aarsland T. Depressed mood and subjective health symptoms as predictors of mortality in patients with heart failure: a two-year follow-up study. Int J Psychiatry Med 1999;29:311-26.
15. Johnson G, Carson P, Francis GS, Cohn JN. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group. Circulation 1993;87:VI32-VI39.
16. Bennett SJ, Pressler ML, Hays L, Firestine LA, Huster GA. Psychosocial variables and hospitalisation in persons with chronic heart failure. Prog Cardiovascular Nurs 1997;12:4-11.
17. Zannad F, Briançon S, Juillière Y, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. J Am Coll Cardiol 1999;33:734-42.
18. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 1992;124:1017-25.
19. Briançon S, Alla F, Méjat E, et al. Mesure de l'incapacité fonctionnelle et de la qualité de vie dans l'insuffisance cardiaque. Adaptation transculturelle et validation des questionnaires de Goldman, du Minnesota et de Duke. Arch Mal Coeur Vaiss 1997;90:1577-85.
20. Alla F, Briançon S, Juillière Y, Mertes PM, Villemot JP, Zannad E Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study. Am Heart J 2000;139:895-904.
21. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187-202.
22. Tarone RE. Tests for trend in life table analysis. Biometrika 1975;62:679-82.
23. Dixon WJ. BMDP Statistical Software Manual. Berkeley, CA: University of California Press, 1992.
24. Rumsfeld JS, MaWhinney S, McCarthy M, et al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. J Am Med Assoc 1999;281:1298-303.
25. Lim LLY, Johnson NA, O'Connell RL, Heller RF. Quality of life and later adverse health outcomes in patients with suspected heart attack. Aust N Z J Public Health 1998;22:540-6.
26. Chocron S, Etievent JP, Viel JF, et al. Preoperative quality of life as a predictive factor of 3-year survival after open heart operations. Ann Thorac Surg 2000;69:722-7.
27. Guyatt GH, Thompson PJ, Berman LB, et al. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985;38:517-24.
28. Francis GS, Rector TS. Maximal exercise tolerance as a therapeutic end point in heart failure-are we relying on the right measure? Am J Cardiol 1994;73:304-6.
29. Wilson JR, Rayos G, Yeoh TK, Gothard P, Bak K. Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation 1995;92(1):47-53.
30. Marwick TH, Zuchowski C, Lauer MS, Secknus MA, William J, Lytle BW. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 1999;33:750-8.
31. Moser D, Worster PL. Effect of psychological factors on physiologic outcomes in patients with heart failure. J Cardiovasc Nurs 2000;14:106-15.
32. Murberg TA, Bru E, Aarsland T, Svebak S. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med 1998;28:273-91.
33. Spertus JA, McDonell M, Woodman CL, Fihn SD. Association between depression and worse disease-specific functional status in outpatients with coronary artery disease. Am Heart J 2000;140:105-10.
34. Hawthorne MH, Hixon ME. Functional status, mood disturbance and quality of life in patients with heart failure. Progress Cardiovasc Nurs 1994;9:22-32.
35. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580-92.
36. Shapiro PA, Lesperance F, Frasure-Smith N, et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. Am Heart J 1999;137:1100-6.